ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,429,000 | +9.1% | 235,611 | +21.2% | 0.01% | 0.0% |
Q3 2016 | $4,059,000 | -18.6% | 194,380 | -0.6% | 0.01% | -16.7% |
Q2 2016 | $4,988,000 | +10.8% | 195,560 | +14.9% | 0.01% | 0.0% |
Q1 2016 | $4,502,000 | -36.0% | 170,198 | +3.6% | 0.01% | -33.3% |
Q4 2015 | $7,029,000 | +62.3% | 164,304 | +0.6% | 0.01% | +50.0% |
Q3 2015 | $4,331,000 | -21.3% | 163,354 | -1.0% | 0.01% | -14.3% |
Q2 2015 | $5,500,000 | +18.9% | 165,005 | +18.7% | 0.01% | +16.7% |
Q1 2015 | $4,626,000 | -25.4% | 139,003 | -8.3% | 0.01% | -25.0% |
Q4 2014 | $6,197,000 | +20.0% | 151,639 | -0.5% | 0.01% | +14.3% |
Q3 2014 | $5,163,000 | -5.6% | 152,384 | -6.1% | 0.01% | 0.0% |
Q2 2014 | $5,472,000 | +7.0% | 162,330 | +20.4% | 0.01% | 0.0% |
Q1 2014 | $5,112,000 | +30.7% | 134,847 | +0.7% | 0.01% | +16.7% |
Q4 2013 | $3,910,000 | -15.5% | 133,899 | -1.1% | 0.01% | -25.0% |
Q3 2013 | $4,629,000 | +8.8% | 135,343 | +5.0% | 0.01% | 0.0% |
Q2 2013 | $4,254,000 | – | 128,937 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |